Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW).

Antiosteoporosis medication (AOM) does not abolish fracture risk, and some individuals experience multiple fractures while on treatment. Therefore, criteria for treatment failure have recently been defined. Using data from the Global Longitudinal Study of Osteoporosis in Women (GLOW), we analyzed ri...

詳細記述

書誌詳細
主要な著者: Díez-Pérez, A, Adachi, J, Adami, S, Anderson, F, Boonen, S, Chapurlat, R, Compston, J, Cooper, C, Gehlbach, S, Greenspan, S, Hooven, F, LaCroix, A, Nieves, J, Netelenbos, J, Pfeilschifter, J, Rossini, M, Roux, C, Saag, K, Silverman, S, Siris, E, Wyman, A, Rushton-Smith, S, Watts, N
フォーマット: Journal article
言語:English
出版事項: 2014